Agree 100%. Anything FDA approves ahead of any ind
Post# of 148109
I look @ Cytodyn as 20% / safety metric, for success.
If LL performs @ a minimum of that range % improvement, over whichever head to head drug or even LL Vs a combo trial.................
Then our safety will bring it home for the win.
Every single time.
......... Leronlimab becomes dominant.
( of course, even with efficacious being the same, is good enough...but I'm just trying to ( for now ) stay void of over excitement by creating a hypothetical % number )
: )